In the News

486 News Items found
Bees in a hive
In the Lab
Findings about proteins called molecular chaperones are shedding new light on possible approaches to cancer treatment.
Two Fred’s Team runners wearing orange shirts in a crowd
Learn about how our donor community is funding life-changing cancer research at Memorial Sloan Kettering and ensuring a brighter future for people with cancer around the world.
Archival photo of Maria Jasin and Mary Ellen Moynahan
From Breaks to Breakthroughs
Maria Jasin’s discoveries have led to concrete advances in patient care. The targeted medicines called PARP inhibitors, for example, are based on knowledge gained from her work.
Albert Kuchler with MSK medical oncologist Bob Li.
Computational biology is helping to bring predictive power and precision to oncology.
Ming Li
Study by study, Dr. Ming Li's lab at MSK is sharing new insights into the molecular and cellular mechanisms involved in immune regulation.
Black-and-white microscopic image of cell from human granular cell tumor
In the Lab
Studying the genes of granular cell tumors has revealed a previously unknown process through which cells can turn cancerous.
An illustration of a magnifying glass over a brain.
Finding
A targeted approach being developed to treat certain cancers may also be effective for Alzheimer’s disease.
An MSK scientist pipettes in the lab
MSK Research Highlights, May 18, 2023
New MSK research shows how high-risk neuroblastoma evolves to be so deadly; finds continued safety and efficacy for sotorasib in patients with KRAS G12C-mutated advanced non-small cell lung cancer; and demonstrates promise in eradicating tumors by delivering a viral-based immunotherapeutic to melanoma and breast cancer in mouse models.
Pictured: Kenneth Offit
In the Lab
Researchers have found the first evidence that susceptibility to developing acute lymphoblastic leukemia during childhood may be heritable.
MSK gynecologic surgeon Dr. Mario Leitao and Dr. Anh Le.
Patient Story
Read about a medical student treated at MSK for aggressive cervical cancer who later returned to train alongside MSK surgeons.